Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
BPC-157 has been investigated in Phase II clinical trials for inflammatory bowel disease therapy, where it demonstrated a favorable safety profile with no reported toxicity or adverse effects
Labeling includes lot numbers, expiration dates, and storage instructions
Compound Class BPC-157 / TB-500 Mix IUPAC Form Research Peptide Vial Size 10mg Purity Assay 99% Identity Confirmed LC-MS confirmed Appearance White lyophilised powder Storage 20C lyophilised, 28C reconstituted Certificate COA listed per lot About This Material BPC-157 / TB-500 Mix This combination vial pairs two of the most-studied tissue-repair peptides 10mg of BPC-157 (Body Protection Compound-157) with 10mg of TB-500 (Thymosin Beta-4 fragment 17-23) giving researchers a single reagent for examining complementary repair pathways such as angiogenesis-linked signalling, cell migration and matrix remodelling
Adverse Reactions/Side Effects Mild transient diarrhea, polycythemia vera, peripheral vascular thrombosis, itching transitory exanthema, feeling of swelling of entire body, anaphylactic shock and death
This migration-promoting activity gives TB-500 a more systemic character than BPC-157
.jpg)